ASAH2 and astrocytoma (excluding glioblastoma): Indeed, a comparison of SMPD3 and ASAH2 proteins levels in these cell lines show an upregulation of the sphingolipid degradation pathway in both oligodendroglioma as well as astrocytoma (Figure 3e,f, Figure S1).